Skip to content
Luna Metabolic
Menu

Advertising disclosure We may earn a commission if you start care through some of these links, at no extra cost to you. How we're funded. Order reflects our editorial rubric and our commercial relationships; scores are ours alone.

Head-to-head for women

Care Bare Rx vs Pallas Health

Care Bare Rx and Pallas Health both offer GLP-1 telehealth to women, but they make different trade-offs on PCOS and hormonal suitability, clinical oversight, price and access. Here they are side-by-side on the Luna Fit Score — our women's-health rubric.

Care Bare Rx

Ranked #28 for women · Grade B−

Best for: Women who want a needle-free route or a brand-name option on the same account, and who care more about knowing who is prescribing than about seeing the exact dose price before they start the intake.

Visit Care Bare Rx
vs

Pallas Health

Higher score

Ranked #16 for women · Grade B−

Best for: Readers who want a general compounded GLP-1 program with unusually specific disclosure about who prescribes and who dispenses, and who can absorb a $597 charge four weeks after the $139 one — not readers looking for PCOS or perimenopause care, which Pallas does not offer.

Visit Pallas Health

The verdict for women

Higher Luna Fit Score: Pallas Health

Pallas Health edges out Care Bare Rx on the Luna Fit Score, 82 to 80 (B− vs B−). Readers who want a general compounded GLP-1 program with unusually specific disclosure about who prescribes and who dispenses, and who can absorb a $597 charge four weeks after the $139 one — not readers looking for PCOS or perimenopause care, which Pallas does not offer. The reasoning behind that number is in the Pallas Health scorecard.

Care Bare Rx is still a genuine option — one of the few programs here that puts both molecules in an oral form as well as an injection, alongside a real brand-name Ozempic lane — and it names the physicians behind the prescription, which few rows here do. Weigh the six women's-health factors below against your own priorities; our full Care Bare Rx review goes through each of them, and if neither of these two is the one, the full field we rank against Care Bare Rx widens the field.

Side-by-side on the six factors

Both providers scored on the same women's-health rubric — the higher side on each factor is marked. See the methodology.

Care Bare Rx Pallas Health
PCOS & hormonal suitability8174
Care
Pallas
Clinical oversight & labs8185
Care
Pallas
Price transparency7278
Care
Pallas
Nationwide access9694
Care
Pallas
Ongoing support7878
Care
Pallas
Cancellation fairness7084
Care
Pallas

Price, access & features

DetailCare Bare RxPallas Health
Luna Fit Score80/100 · B−82/100 · B−
Overall rank#28#16
SemaglutideFrom $199/mo (per-dose price quiz-gated)$199/mo average — Pallas's own figure for $597 billed every 12 weeks, which is its only cadence; $139 covers the first 4 weeks, after which the next charge is $597 in one payment
TirzepatideFrom $199/mo (per-dose price quiz-gated)$299/mo average — Pallas's own figure for $897 billed every 12 weeks, which is its only cadence; $179 covers the first 4 weeks, after which the next charge is $897 in one payment
CoverageAll 50 states and Puerto RicoAll 50 states and Washington D.C. — asynchronous in 43; Arkansas, Mississippi, New Mexico, North Dakota, Rhode Island, South Dakota, West Virginia and D.C. require one video visit
Brand-name accessYesYes
Oral / sublingualYesInjection only

Care Bare Rx

Ranked #28 · Grade B−

What we like

  • Both molecules in two routes — compounded injectable semaglutide and tirzepatide, plus oral semaglutide (Rybelsus®) and an oral tirzepatide formulation
  • A genuine brand-name lane with its price on the page: Ozempic® injection from $705/mo, published rather than quoted on request
  • Names its prescribers with NPI numbers — Dr. Ana Lisa Carr, MD and Dr. Kelly Tenbrink, MD — which is rarer in this ranking than it should be

The caveats

  • Compounded medication is not FDA-approved the way brand Ozempic, Wegovy, or Zepbound are
  • Publishes one "From $199/mo" weight-loss figure that names no molecule; the per-dose price is quiz-gated inside the intake app, and the FAQ only says "price varies by dose and medication prescribed"
  • No published lab or monitoring program, which matters more if hormones are part of your picture

Pallas Health

Ranked #16 · Grade B−

What we like

  • Names all six dispensing pharmacies in public — Belmar, Strive, Epiq Scripts, Casa Pharma Rx, The Pharmacy Hub and Foothills — with the 503A and 503B distinction explained, where almost everything else in this category names none
  • Names two prescribing physicians with their NPI numbers and links out to the NPPES registry so you can check them yourself: Dr. Ana Lisa Carr, MD (family medicine, NPI-verified, licensed in 15 states) and Dr. Kelly Tenbrink, MD (emergency medicine, NPI-verified, Tennessee and Florida). Pallas additionally claims obesity and addiction medicine board certifications for Dr. Carr, which NPPES does not carry either way
  • The advertised price is the checkout price — the homepage FAQ, the landing pages, the treatment pages and the live funnel all state the same four figures, and no different number appears at payment

The caveats

  • There is no month-to-month rung. The funnel renders no cadence selector at all: semaglutide is $139 for the first four weeks and then $597 billed every 12 weeks, so the second charge is $597 in one payment four weeks after the first — tirzepatide, $179 then $897 — and the advertised “$199/mo average” is that 12-week prepay divided by three rather than a price anyone is billed
  • Twelve weeks is not three months. On Pallas's own published renewal terms the charge recurs every 84 days — 4.35 times a year, not four — so semaglutide's first year is $139 + 4×$597 = $2,527, or $210.58/mo, and the steady state is $2,596 a year, about $216/mo, against $199 advertised. Tirzepatide runs $3,767 in year one ($313.92/mo) and about $3,900 a year after (~$325/mo) against $299. The advertised average understates the ongoing rate by roughly 8.7%
  • No women's-health program of any kind. Pallas's own women's-health category exists only as “coming soon”; there is no PCOS track, no perimenopause track and no cycle-aware protocol, and neither named physician is an OB-GYN or a women's-health specialist. What is on offer here is a general compounded GLP-1 program, and it should be read as one

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. Pricing, states and verification reflect each provider's public disclosures at last review; the Luna Fit Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

More head-to-heads

Neither Care Bare Rx nor Pallas Health is only worth comparing with the other. Care Bare Rx is also written up against CoreAge Rx, 13 points apart on the Luna Fit Score — see Care Bare Rx vs CoreAge Rx for women. Pallas Health is also written up against CoreAge Rx, 11 points apart — see Pallas Health against CoreAge Rx, factor by factor.

Or browse the full comparison hub.